5//SEC Filing
Huntsman Ronald Kirk 5
Accession 0001493152-22-004603
CIK 0001716166other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 9:21 PM ET
Size
5.6 KB
Accession
0001493152-22-004603
Insider Transaction Report
Form 5
Huntsman Ronald Kirk
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2021-06-16$5.64/sh+125,000$705,000→ 125,000 totalExercise: $5.64Exp: 2026-06-26→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]An option for the purchase of 125,000 shares was granted on June 16, 2021. The option vests one fifth immediately and one-fifth annually on each anniversary date through June 16, 2025.
Documents
Issuer
Vivos Therapeutics, Inc.
CIK 0001716166
Entity typeother
Related Parties
1- filerCIK 0001835498
Filing Metadata
- Form type
- 5
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 9:21 PM ET
- Size
- 5.6 KB